NasdaqCM:BLFSLife Sciences
BioLife Solutions (BLFS) Q4 Profitability Glimpse Tests Bullish Margin Narratives
BioLife Solutions (BLFS) just closed out FY 2025 with Q4 revenue of US$24.8 million and basic EPS of US$0.04, alongside net income from continuing operations of US$2.1 million and earnings from discontinued operations of US$9.0 million. The company reported quarterly revenue moving from US$21.4 million in Q3 2024 to US$28.1 million in Q3 2025, while basic EPS was US$0.04 in both Q4 2024 and Q4 2025. This raises a key question for investors: how much of that top line is turning into...